07:00 , Apr 6, 2009 |  BC Week In Review  |  Company News

Axikin, Proteros deal

Proteros will develop assays and use its X-ray crystallography to determine the structure of an undisclosed protein provided by Axikin. Proteros also will use its fragment library and industrial crystallography to determine the binding mode...
08:00 , Feb 9, 2009 |  BC Week In Review  |  Company News

Actimis Pharmaceuticals pulmonary, inflammation news

Actimis completed its previously announced spinout of Axikin Pharmaceuticals Inc. to develop four undisclosed preclinical small molecules to treat severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses,...